Literature DB >> 15571546

Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit.

Molly M Shores1, Victoria M Moceri, David A Gruenewald, Kayla I Brodkin, Alvin M Matsumoto, Daniel R Kivlahan.   

Abstract

OBJECTIVES: To evaluate whether low testosterone levels are associated with greater depression or poorer function in a geriatric rehabilitation unit.
DESIGN: Retrospective review.
SETTING: Geriatric rehabilitation unit. MEASUREMENTS: Low testosterone levels were defined as total testosterone of 3.0 ng/mL or less or free testosterone of 9.0 pg/mL or less. Age, ethnicity, weight, depression, ambulation, length of rehabilitation, and 6-month rehospitalization and mortality rates were obtained. Overall illness severity was determined using the Cumulative Illness Rating Scale for Geriatrics.
RESULTS: Low testosterone levels were present in 29 of 44 (65.9%) men. There were no significant differences between men with low and normal testosterone levels in ethnicity, age, weight, depression, and overall illness severity. Lower testosterone levels were correlated with decreased ability to ambulate and transfer (Spearman P>.34; P<.05). There were no significant differences between men with low and normal testosterone in length of stay on the rehabilitation unit (mean+/-standard deviation= 19.6+/-11.6 vs 17.7+/-17.5 days, P=.68) or rehospitalization rates (41.4% vs 26.7%; P=.34). Men with low testosterone had a trend toward increased 6-month mortality (31.0% vs 6.7%; chi(2)=3.3, P=.07) and shorter survival time (log rank=3.2; df 1, P=.07). After entering testosterone and variables with potential prognostic significance for mortality in a stepwise manner in a Cox regression analysis, there was a significant mortality risk associated with low testosterone (hazard ratio=27.9, 95% confidence interval=2.0-384.0; P=.01).
CONCLUSION: Low testosterone levels were correlated with decreased physical function and increased risk for 6-month mortality. Prospective studies with larger sample sizes and better standardized testosterone measures are needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571546     DOI: 10.1111/j.1532-5415.2004.52562.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  21 in total

Review 1.  Andropause: is the emperor wearing any clothes?

Authors:  S H Tariq; M T Haren; M J Kim; J E Morley
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 2.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

Review 3.  Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis.

Authors:  Andre B Araujo; Julia M Dixon; Elizabeth A Suarez; M Hassan Murad; Lin T Guey; Gary A Wittert
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

4.  The Anxiolytic and Antidepressant-like Effects of Testosterone and Estrogen in Gonadectomized Male Rats.

Authors:  Nicole Carrier; Samantha K Saland; Florian Duclot; Huan He; Roger Mercer; Mohamed Kabbaj
Journal:  Biol Psychiatry       Date:  2015-01-14       Impact factor: 13.382

5.  Testosterone is not associated with mortality in older African-American males.

Authors:  Lenise A Cummings-Vaughn; Theodore K Malmstrom; John E Morley; Douglas K Miller
Journal:  Aging Male       Date:  2010-08-04       Impact factor: 5.892

6.  Testosterone and insulin resistance in the metabolic syndrome and T2DM in men.

Authors:  Preethi M Rao; Daniel M Kelly; T Hugh Jones
Journal:  Nat Rev Endocrinol       Date:  2013-06-25       Impact factor: 43.330

7.  Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging?

Authors:  Ozkan Gungor; Fatih Kircelli; Juan Jesus Carrero; Gulay Asci; Huseyin Toz; Erhan Tatar; Ender Hur; Mehmet Sukru Sever; Turgay Arinsoy; Ercan Ok
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 8.237

Review 8.  The role of androgens and estrogens on healthy aging and longevity.

Authors:  Astrid M Horstman; E Lichar Dillon; Randall J Urban; Melinda Sheffield-Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

9.  The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.

Authors:  Farid Saad; Louis J Gooren
Journal:  J Obes       Date:  2010-08-10

10.  Low serum testosterone and mortality in older men.

Authors:  Gail A Laughlin; Elizabeth Barrett-Connor; Jaclyn Bergstrom
Journal:  J Clin Endocrinol Metab       Date:  2007-10-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.